FDA, CDC Warn of Misuse of Fingerstick, Point-of-Care Blood Testing Devices

The FDA has issued a safety alert about the potential for bloodborne infection transmission associated with misuse of fingerstick devices and point-of-care blood testing devices, including blood glucose meters and cholesterol testing devices. At the same time, the CDC has updated its safety information for clinicians related to this topic.